Further Studies on Oxygenated Tryptamines with LSD-like Activity Incorporating a Chiral Pyrrolidine Moiety into the Side Chain-Reference-Cited by-同舟云学术

Further Studies on Oxygenated Tryptamines with LSD-like Activity Incorporating a Chiral Pyrrolidine Moiety into the Side Chain

Published:1999-09-16 Issue:20 Volume:42 Page:4257-4263
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Gerasimov Madina¹,Marona-Lewicka Danuta¹,Kurrasch-Orbaugh Deborah M.¹,Qandil Amjad M.¹,Nichols David E.¹

Affiliation:

1. Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm990325u

Reference15 articles.

1. 5-[(3-Nitropyrid-2-yl)amino]indoles: Novel Serotonin Agonists with Selectivity for the 5-HT1D Receptor. Variation of the C3 Substituent on the Indole Template Leads to Increased 5-HT1D Receptor Selectivity

2. Stereoselective Synthesis of trans-2-(Indol-3-yl)cyclopropylamines: Rigid Tryptamine Analogs

3. Synthesis and Serotonin Receptor Affinities of a Series of trans-2-(Indol-3-yl)cyclopropylamine Derivatives

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serotonin 2A Receptor (5-HT_2AR) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants;Chemical Reviews;2023-11-30

2. Bioinspired Formal Synthesis of Pancracine via Selective Hydrogenation of an Indole Derivative;Synlett;2023-01-28

3. The Diverse Reactivity of Homopropargylic Amines as “Masked” 1C Synthons for the Aza-Friedel-Crafts Alkylation of Indoles;European Journal of Organic Chemistry;2018-01-24

4. Parallel artificial membrane permeability assay for blood–brain permeability determination of illicit drugs and synthetic analogues;Science & Justice;2014-09

5. Some new psychoactive substances: Precursor chemicals and synthesis-driven end-products;Drug Testing and Analysis;2011-07